Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 97 Results

Intervention Indication Therapeutic Area Year Actions
Atezolizumab with chemotherapy for treating recurrent triple-negative breast cancer Atezolizumab (Tecentriq; MPDL3280A) , Chemotherapy Breast cancer Breast Cancer 2022 View  |  Download
Atogepant for prevention of migraine Atogepant (AGN-241689; MK-8031) Migraine Neurology 2022 View  |  Download
Bardoxolone Methyl for the treatment of chronic kidney disease (CKD) caused by Alport Syndrome Bardoxolone Methyl Alport Syndrome , Chronic kidney disease (CKD) Genetic Disorders , Nephrology 2022 View  |  Download
Baricitinib for treating atopic dermatitis in children and adolescents Baricitinib (LY3009104; Olumiant) Atopic dermatitis Dermatology 2022 View  |  Download
Baricitinib for treating juvenile idiopathic arthritis in paediatric patients Baricitinib (LY3009104; Olumiant) Juvenile psoriatic arthritis Rheumatology 2022 View  |  Download
Bempegaldesleukin in combination with nivolumab for previously untreated unresectable or metastatic melanoma Bempegaldesleukin (NKTR-214; BMS-986321; NEKTAR) , Nivolumab (Opdivo; BMS-936558; ONO-4538) Melanoma Skin Cancer 2022 View  |  Download
Benralizumab for treating eosinophilic oesophagitis in people aged 12-65 years Benralizumab (Fasenra; MEDI563) Eosinophilic oesophagitis Gastroenterology 2022 View  |  Download
Bimekizumab for Hidradenitis Suppurativa Bimekizumab (UCB4940) Hidradenitis suppurativa (HS) Dermatology 2022 View  |  Download
Canakinumab adjuvant therapy for treating completely
resected non-small-cell lung cancer
Canakinumab (Ilaris; ACZ885) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2022 View  |  Download
Cenobamate as an adjunctive therapy for primary generalised tonic-clonic seizures Cenobamate (YKP3089) Primary generalised tonic-clonic seizures Neurology 2022 View  |  Download
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications